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Abstract
Background Surgical innovation is different from the intro-
duction of novel pharmaceuticals. To help address this, in
2009 the IDEAL Collaboration (Idea, Development,
Exploration, Assessment, Long-term follow-up) introduced
the five-stage framework for surgical innovation. To evaluate
the framework feasibility for novel neurosurgical procedure
introduction, two innovative surgical procedures were exam-
ined: the endoscopic endonasal approach for skull base me-
ningiomas (EEMS) and the WovenEndobridge (WEB device)
for endovascular treatment of intracranial aneurysms.
Methods The published literature on EEMS and WEB de-
vices was systematically reviewed. Identified studies were
classified according to the IDEAL framework stage. Next,
studies were evaluated for possible categorization according
to the IDEAL framework.
Results Five hundred seventy-six papers describing EEMS
were identified of which 26 papers were included. No pro-
spective studies were identified, and no studies reported on
ethical approval or patient informed consent for the innovative
procedure. Therefore, no clinical studies could be categorized
according to the IDEAL Framework. For WEB devices, 6229
articles were screened of which 21 were included. In contrast
to EEMS, two studies were categorized as 2a and two as 2b.
Conclusion The results of this systematic review demonstrate
that both EEMS and WEB devices were not introduced ac-
cording to the (later developed in the case of EEMS) IDEAL
framework. Elements of the framework such as informed con-
sent, ethical approval, and rigorous outcomes reporting are
important and could serve to improve the quality of neurosur-
gical research. Alternative study designs and the use of big
data could be useful modifications of the IDEAL framework
for innovation in neurosurgery.
Keywords IDEAL framework . Innovation . Neurosurgery .
Meningioma . Ethics . Intracranial aneurysm .WEB device
Introduction
Today, it is unusual to perform neurosurgical procedures in
most countries without access to an operative microscope,
state-of-the-art neuro-navigational systems, or even hemostat-
ic agents such as a bipolar electrocautery devices. In fact,
technological innovation has been the hallmark of neurosur-
gery, and the vast majority of procedures that are currently
considered routine would not be possible at all without inno-
vation. However, not all innovation is an improvement over
the technology it seeks to supplant. Evidence of patient
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outcome superiority is often lacking or non-existent in the
real-time of innovation. In neurosurgical disease, low inci-
dence and high burden may further hinder systematic evalua-
tion of any new technique. Regardless of these difficulties, it is
vital that new technologies and procedures undergo a strategic
and ethical clinical introduction [9].
As surgical innovation does not typically follow the same
introductory path as novel pharmaceuticals, the IDEAL
Collaboration, formed by surgeons and methodologists, intro-
duced the IDEAL (Idea, Development, Exploration,
Assessment, Long-term follow-up) framework in 2009 and have
published several updates since [16, 23, 47, 48, 65]. The goal of
the collaboration is to improve surgical research, especially re-
search surrounding innovation, and to overcome obstacles and
methodological problems inherent to surgery [29, 47].
The IDEAL framework describes five stages through
which interventional therapeutic innovations typically pass,
together with the characteristics and study design of each stage
(Table 1, adapted from McCulloch et al.) [16, 23, 47, 48, 65].
Any study involving non-human pre-clinical assessment of a
novel technique, including simulator or animal studies, is
regarded as stage 0. Stage one describes a proof-of-concept
study in the first human patient. Stage 2a consists of a pro-
spective study in up to 30 patients conducted by surgeons
responsible for the earlier stage(s). Involving surgeons with
no prior experience in a larger prospective study usually takes
place in stage 2b to assess the learning curve and further de-
velop the procedure. In stage 3, the procedure should be stable
and is investigated in a randomized controlled trial (RCT) that
compares outcomes of the innovative procedure with the gold
standard. Assessment of rare and long-term outcomes takes
place in stage 4 (Table 1) [29, 47].
To assess whether the IDEAL framework has been used
two different neurosurgical procedures were evaluated: an en-
doscopic endonasal approach for skull base meningiomas
(EEMS) and the use of the Woven Endobridge (WEB device,
©Sequent Medical) for endovascular treatment of intracranial
aneurysms. Traditionally, skull basemeningiomas are resected
using an open transcranial microscopic approach [36].
However, recently, EEMS has been introduced and has gained
some traction in neurosurgical literature [36]. The WEB de-
vice is a new option for intracranial aneurysm treatment,
consisting of an unfoldable, detachable metallic mesh that is
placed into the aneurysm neck leading to flow disruption [35].
TheWEB device was especially developed for bifurcation and
wide neck aneurysms as an alternative to traditional clipping
or coiling [35]. Since the two innovations, one a device and
the other a procedure, are used in different fields of neurosur-
gery and were recently introduced, we chose these two as
examples for neurosurgical innovations in general.
In this review, published literature on these two procedures
was evaluated to assess whether they were introduced accord-
ing to the stages of the IDEAL framework.
Methods
Search strategy and paper selection
This systematic review was conducted in accordance with the
Preferred Reporting Items for Systematic reviews and Meta-
Analyses (PRISMA) statement [50]. The literature search for
EEMS was conducted in PubMed and Embase up to 26
November 2015, using the following keywords: endoscopy,
neurosurgery, endo- and transnasal and meningioma. The
search strategy is provided in Supplemental Digital Content
Table 1a. This search strategy resulted in 576 unique papers.
In addition, bibliographies of the included papers were
screened for relevant papers. For WEB devices, a search was
conducted in the same search engines on 29 May 2016 using
the keywords: WEB device, endovascular treatment, and in-
tracranial aneurysm as depicted in Supplemental Digital
Content Table 1b. This resulted in 6229 articles. These papers
were supplemented by hand searching of the bibliographies of
the papers retrieved by the electronic search. This review was
restricted to published data. Only papers written in English,
Dutch, French, or German were considered for this review.
The search was not limited by date of publication. Titles and
abstracts of retrieved citations were screened by two authors,
and potentially suitable studies for EEMS were read in full by
IM and SD and for WEB devices by IM and JS. We included
papers that solely focused on EEMS as depicted in Fig. 1a
[50]. For WEB devices we included papers reporting out-
comes of treated aneurysms as described in Fig. 1b [50].
Disagreements were solved by reviewer consensus.
Study assessment
Relevant studies were reviewed in full text to determine
whether they could be classified according to an IDEAL stage
by two authors (IM and SD for EEMS and IM and JS for
WEB devices) [47]. The following criteria were used to clas-
sify studies according to the five stages. Pre-clinical studies
were classified as stage 0, and proof of principal in one patient
was regarded as stage 1 if informed consent had been obtained
[47]. Studies were classified as stage 2 if ethical approval for a
prospective study and informed consent for an innovative pro-
cedure from included patients had been obtained. Studies with
up to 20 patients were classified as stage 2a and those with
more than 20 patients as stage 2b. Studies that compared
EEMS or WEB devices with the current gold standard in a
prospective fashion were regarded as stage 3. As an RCT may
not have been feasible for ethical or pragmatic reasons, we
also evaluated studies with different designs [16, 23]. Long-
term follow-up studies were categorized as stage 4. In addition
to study design, ethical approval and informed consent, all
studies were evaluated for reporting surgical or radiological
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outcomes for EEMS and WEB devices studies, respectively.
Disagreements were solved by consensus discussion.
Results
For EEMS, 576 abstracts and titles were screened, 110 were
examined full text, and 26 papers were included (Fig. 1a) [1, 8,
12, 13, 17, 19–21, 24–26, 30, 32, 34, 37, 38, 52–55, 62, 68,
70–73]. Two cadaveric studies were categorized as stage 0
[12, 30]. No studies were categorized as stage 2, as none of
the included studies reported outcomes of a prospective study
with adequate informed consent [1, 8, 13, 17, 19–21, 24–26,
32, 34, 37, 38, 52–55, 62, 68, 70–73]. Even though four stud-
ies compared EEMS with an open transcranial approach, they
did not do this in a prospective fashion, and no RCTs could be
identified [8, 19, 20, 52]. Furthermore, there were no studies
that examined long-term outcomes, and therefore no studies
were categorized as stage 4 (Table 2). All other studies could
not be categorized into an IDEAL stage.
For WEB devices, 6229 abstracts and titles were screened,
88 articles were examined full text, and 21 papers were in-
cluded (Fig. 1b) [2, 5, 10, 11, 14, 15, 22, 27, 33, 35, 41–43, 45,
56–60, 64, 69]. Preclinical studies using rabbit models were
classified as stage 0 [22, 64]. One study that acquired in-
formed consent for treatment of two patients was categorized
as stage 1, but did not describe the clinical problem that need-
ed a solution [35]. Two studies with ethical approval for a
prospective study and informed consent of included patients
were categorized as stage 2a [2, 44]. The studies with larger
populations that reported the outcomes of theWEBCAST trial
and the French observatory trial were categorized as stage 2b
[57, 60]. All other studies could not be categorized into an
IDEAL stage, and no studies were categorized as stage 3 or
4 as no comparison was made with other treatment modalities
and no long-term outcomes were evaluated (Table 3).
Discussion
The results of this systematic review demonstrate that both the
endoscopic endonasal transsphenoidal approach for resection
of skull base meningiomas and WEB devices were not intro-
duced according to the IDEAL Framework. Not only could
not all IDEAL framework stages be identified, some of the
early pre-clinical studies (stage 0) were performed long after
the description of the first-in-man studies (for EEMS) or after
publication of prospective studies (WEB devices) [12, 22, 30,
64]. Perhaps unsurprisingly, only five clinical studies could be
categorized into an IDEAL stage.WEB device studies follow-
ed the IDEAL Framework more closely than EEMS, but only
up to stage 2b [2, 35, 45, 57, 60]. In addition, only six WEB
device studies acquired ethical approval for a prospective
study in line with the IDEAL framework [2, 27, 45, 56, 60,
61]. No study reported patient selection for EEMS compared
to five WEB device studies [27, 41, 45, 57, 60]. Furthermore,
no studies were categorized as stage 3 as no clinical study (of
Table 1 Overview of the IDEAL framework, adapted from McColloch [47]
Purpose 1: Idea 2a: Development 2b: Exploration 3: Assessment 4: Long-term study
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either procedure) was a prospective comparison with the gold
standard or was an RCT.
We believe that this is not unique to these two procedures
specifically or to neurosurgery in general. For instance, a
study investigating literature on laparoscopic colonic polyp
resection found that its introduction into widespread use also
did not follow the stages and recommendations of the IDEAL
framework [18].
The introduction of novel neurosurgical techniques that
result in a paradigm change, i.e., the first endovascular treat-
ment of aneurysms, could be introduced according to some
predefined framework such as IDEAL. However, in reality,
novel surgical techniques are often the result of small stepwise
changes to existing approaches (e.g., EEMS and the transcra-
nial approach to pituitary adenomas). This makes it challeng-
ing to introduce innovations as EEMS according to all require-
ments of the IDEAL framework. Adherence to the IDEAL
framework might not only be challenging because of small
stepwise changes of existing approaches but also because of
a lack of a universally accepted definition of neurosurgical
innovation in general.
A major change in endonasal surgery was the introduction
of the endoscope, in particular for pituitary adenomas [31].
With expansion of endoscopic technique and experience, a
wider spectrum of tumors became resectable through the
endonasal approach. However, in retrospect, one could argue
that EEMS is indeed a valuable alternative to a classic crani-
otomy for specific indications.
The WEB device is also example of expanding
endovascular experience, and because of new endovascular
devices a wider array of pathologies is treatable. Compared
to EEMS,WEB devices were studied in a prospective fashion
with patient informed consent [2, 45, 57, 60]. However, the
WEB device is already used clinically despite lack of compar-
ison with other treatment options (a stage 3 study) [11, 14, 69].
The important question is whether this new technique could
have been rigorously compared to established techniques prior
to wide-spread adoption.
Overall, this review suggests that neurosurgical innovation
(at least for the two procedures evaluated here) has not histor-
ically followed the IDEAL framework. On the one hand, this
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framework. On the other hand, a different distinct possibility
for this could be related to feasibility. The IDEAL collabora-
tion recognizes that, to improve the quantity and quality of
surgical research, these proposals/recommendations would
have to be practical and adapted to the process of innovation
[47]. Indeed, the IDEAL Collaboration supports several rec-
ommendations for specific (alternative) study designs and
reporting standards at different stages of the framework [16,
23, 47]. These alternatives could contribute to the quantity and
quality of neurosurgical research.
At the innovation stage (stage 1), the recommendations in-
clude online registries for first-in-man innovations. No reports on
the entry of a study in a registry were found in our review. Often
in neurosurgery innovations take place in an acute setting, and
only in retrospect is there clarity with regards to the innovation
itself. However, it is possible that future innovations could be
entered in a registry, especially in the case of new devices like
the WEB device. Registries could help reduce positive reporting
bias inherent to new innovations. Reports of both successes and
failures of new technology are useful for ethical innovation [51].
At the second development stage recommendations in-
clude: prospective development studies, protocol and study
registries for prospective development studies in surgery and
development of agreed reporting standards and definitions for
key outcomes [29, 47]. These recommendations were not met
for the introduction of EEMS and by only four studies for
WEB devices [2, 45, 57, 60].
Again, not all of these recommendations may be possible
in neurosurgery. However, protocol and prospective study
registries are feasible in the neurosurgical field and could help
ensure that clinical results of all patients are transparent and
methodologically sound. Furthermore, novel techniques could
be reported using professionally accepted reporting guidelines
for prospective (and if inapplicable, retrospective) studies that
favor clear interpretation of the study design and study results.
Also, open comparison of individual studies and applicability
of the reported outcomes would be useful. Key patient-
centered outcomes for various pathologies result in research
with comparable and clinically meaningful results.
All studies described the surgical outcomes, and this is
outstanding. One next step could be to unify informed consent
and outcomes reporting, which should include both positive
and negative findings, for emerging innovative procedures.
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a more uniform manner across the neurosurgical field. One
method might be the use of centralized regulation as seen with
medical device approval by the Food and Drug
Administration (FDA) [39, 40]. Alternatively, institutions or
neurosurgical societies could create guidelines for reporting of
trial registration, prospective design and patient registries, ef-
fectively following the IDEAL framework to a certain extent
[48]. Nevertheless, informed consent and ethical approval for
a prospective study are, we believe, something that should
always be feasible when evaluating a new neurosurgical
procedure.
No prospective randomized studies or RCTs, the ‘default
option’ at the third or exploration stage of the IDEAL frame-
work, were identified [47]. This may be one area of the
IDEAL framework that is not completely feasible in all types
of neurosurgical innovation. As discussed, innovation occurs
by incremental but gradual changes over a prolonged period
of time, and an RCT may not be the preferred study design for
numerous reasons: (1) It is ethically challenging and practical-
ly impossible to compare EEMS to an open approach as the
endonasal approach is not applicable to all patients; (2) the
number of patients with skull base meningiomas is relatively
small, which makes it difficult to recruit enough patients for
proper statistical analyses; (3) the difference in outcomes be-
tween an open and endonasal approach might be small and
therefore difficult to prove, especially with point 2 inmind; (4)
there could be a lack of clinical equipoise; (5) surgeons might
not be willing to participate because of personal treatment
preference or experience [46]; (6) surgeons have different skill
levels; (7) the location, extent and size of meningiomas vary,
complicating inter-patient comparability and randomization,
again complicated by point 3; (8) concomitant factors can
change during the trial, e.g., innovation in anesthesiology
and perioperative care [6, 49]; (9) improvement of endoscopic




















Cavallo et al. (2005) [12] 0 NA NA NA NA 0
Jacquesson et al. (2015) [30] 0 NA NA NA NA 0
Alexander et al. (2010) [1] 1 N N Y N None
Bowers et al. (2011) [8] 27 N N Y N None
Chowdhury et al. (2012) [13] 6 N N Y N None
Cook et al. (2004) [17] 3 N N Y N None
De Almeida et al. (2015) [19] 20 N N Y N None
De Divitiis et al. (2008) [20] 51 N N Y N None
De Divitiis et al. (2008) [21] 11 N N Y N None
Fernadez-Miranda et al. (2012)
[24]
1 N N Y N None
Gadgil et al. (2013) [25] 5 N N Y N None
Gardner et al. (2008) [26] 35 N N Y N None
Julian et al. (2014) [32] 1 N N Y N None
Khan et al. (2014) [34] 46 N N Y N None
Koutourousiou (2014) [37] 75 N N Y N None
Koutourousiou (2014) [38] 50 N N Y N None
Mortazavi et al. (2015) [52] 27 N N Y N None
Ogawa et al. (2012) [53] 19 N N Y N None
Ottenhausen et al. (2014) [54] 20 N N Y N None
Padhye et al. (2012) [55] 15 N N Y N None
Prevedello et al. (2007) [62] 1 N N Y N None
Van Gompel et al. (2011) [68] 13 N N Y N None
Wang et al. (2009) [71] 7 N N Y N None
Wang et al. (2010) [70] 12 N N Y N None
Wang et al. (2015) [72] 1 N N Y N None
Webb-Myers et al. (2008) [73] 1 N N Y N None
The Y (Yes) means the study meets the IDEAL framework recommendations. The N (No) means the study did not meet the IDEAL framework
recommendations. NA Not applicable
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endonasal meningioma surgery is a constantly evolving pro-
cess with differences in every center, which contributes to the
often reported difficulty in standardization for innovative sur-
gical procedures, it is inefficient to conduct an RCT for every
incremental technological advance, and the incidence of these
lesions is quite low [6]. For these reasons, a Bclassical^ RCT
in low-volume, highly complex cases as with skull base me-
ningioma resections or similar procedures might not be feasi-
ble. However, the IDEAL collaboration endorses various al-
ternatives to this trial design at the third stage. These include
case-matching studies and controlled interrupted-time series
designs, but also modified RCTs with Baysean modifications
to recruitment, randomization or analysis [47]. These study
designs might be useful in neurosurgical innovation.
Especially the introduction of prospective research databases
and collaborative studies, endorsed by the IDEAL collabora-
tion, seem valuable for low-volume, highly complex surgeries
such as skull base meningioma resections. Also, the recom-
mended additions to the RCTs that include learning curve
evaluation, quality control and compliance measures could
be feasible and helpful for innovations as EEMS.
Even though an RCT for WEB devices could be challeng-
ing, especially because of the above-mentioned reasons 3–9,
an RCT is possible and could have been conducted prior to
wide-spread European adoption [35]. However, in the absence
of a traditional RCT, a Baysian RCT or registry could have
also been helpful to establish its efficacy and safety. In fact,
application of all stages of the IDEAL framework in a more
strategic fashion could be possible in technological innova-
tions like the WEB device. To date, the WEB device appears
to be efficacious and safe, but a more rigorous and transparent
process for the introduction of this type of technology could
potentially help prevent deleterious outcomes, as seen with the
Poly Implant Prothèse (PIP) breast implants and metal-on-
metal hip prostheses [4, 28, 67]. Currently, proof of safety
and efficacy is required by the FDA for class III devices (the
most invasive devices), but this is not standardized [39, 40].
Therefore, a change in regulation that results in a closer ad-
herence to the IDEAL framework could lead to a more uni-
form implementation [48].
At the fourth or long-term study stage, the emphasis is on rare
and long-term outcomes. We did not identify any (stage 4) stud-
ies reporting long-term outcomes of EEMS orWEB devices.We
believe that in addition to a closer adherence to the ‘IDEA’ part of
the IDEAL framework, attention to the long-term outcomes of
innovations such as EEMS or WEB devices would greatly















Ding et al. (2011) [22] 24 (rabbits) NA NA NA N 0
Rouchaud et al. (2016) [64] 80 (rabbits) NA NA NA N 0
Ambrosi et al. (2015) [2] 10 Y Y Y N 2a
Behme et al. (2015) [5] 52 N N Y N None
Caroff et al. (2014) [10] 6 N N Y N None
Caroff et al. (2015) [11] 98 N N Y N None
Clajus et al. (2016) [14] 108 N Ya Y N None
Colla et al. (2013) [15] 4 N N Y N None
Gherasim et al. (2015) [27] 10 Y N Y N None
Kabbasch et al. (2016) [33] 43 N N Y N None
Klisch et al. (2011) [35] 2 N Y Y N 1
Lawson et al. (2016) [41] 23 N N Y N None
Lescher et al. (2016) [42] 22 N N Y N None
Liebig et al. (2015) [43] 47 N N Y N None
Lubicz et al. (2013) [44] 19 Y Y Y N 2a
Papagiannaki et al. (2014) [56] 83 Y N Y N None
Pierot et al. (2013) [58] 33 N N Y N None
Pierot et al. (2015) [59] 45 N N Y N None
Pierot et al. (2016) [57] 51 Y Y Y N 2b
Pierot et al. (2016) [60] 62 Y Y Y N 2b
Van Rooij et al. (2016) [69] 32 N N Y N None
The Y (Yes) symbol means the study met the IDEAL framework recommendations. The N (No) symbol means the study did not meet the IDEAL
framework recommendations
a Informed consent was only obtained in cognitively intact patients
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benefit innovation in neurosurgery. Registries are an appropriate
study design for this purpose, although representativeness of the
data is a potential limitation. Efforts made to ensure that data
entry is complete help strengthen the representativeness of the
registry [47]. Reporting fatigue can compromise comprehensive
data collection; therefore, the development of concentrated, out-
come relevant registries are optimal. Also, the use of registries
with patient informed consent for surveillance of specific
established techniques in neurosurgery is desirable, especially
for use of new materials like the WEB device.
In general, innovation in low-volume, highly complex
(neuro)surgical cases might benefit from alternatives to tradi-
tional RCTs. For example, in a Bcohort multiple RCT,^ some,
but not all, patients are randomly assigned to a specific treat-
ment and are followed up regularly over time, blending a RCT
with an observational study with some of their respective ben-
efits [7, 63, 66]. A potential stage 3 study on a low-volume,
highly complex surgical innovation could include the follow-
ing: (1) patient informed consent; (2) ethical approval; (3)
strict definition (and registration) of indications for treatment;
(4) prospective observational design; (5) registration in a trial
registry; (6) random allocation of a standard treatment group
or the well-defined innovative procedure; (7) regular follow-
up on relevant outcomes for patients; (8) reporting of all out-
comes; (9) collaboration of multiple centers.
This, however, does not address the issue of which inno-
vative procedures merit such a study. BBig data^ could fill the
gap with regard to identification of trial-worthy innovations.
The use of the electronic medical record, the digitization of
patient outcomes and the computational capacity now avail-
able to the typical researcher have opened the door to detailed
and comprehensive analysis of pre-trial data. Indeed, these
types of large data sets could become a new level of evidence
in and of itself if an RCT is not feasible [3].
Conclusion
The introduction of EEMS and WEB devices did not follow
the stages as described by the IDEAL framework. The intro-
duction of WEB devices followed the IDEAL Framework
more closely, but only up to stage 2b. We believe this is not
unique to neurosurgery or to these techniques, and it simply
may not be feasible to follow this framework in its current
iteration for all types of innovation. Despite this, informed
consent, ethical approval and rigorous outcomes reporting
are important elements of the IDEAL framework, which could
serve to improve the quality of both experimental and alterna-
tive neurosurgical study designs. Alternatives to traditional
RCTs and the use of Bbig data^ could be useful modifications
of the IDEAL framework. We believe that neurosurgical in-
novation and research could be improved by following a
framework such as (a modified version of) IDEAL. This
would improve evidence-based practice and potentially pa-
tient outcomes. After all, methodologically sound prospective
studies, which require informed consent, ethical approval and
equipoise, are feasible in neurosurgery.
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